Human thyroid autoantigens and proteins of yersinia and borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor

Thyroid

Volumn 16, Issue 3, 2006, Pages 225-236

  Benvenga, Salvatore ^a,b   Santarpia, Libero ^a   Trimarchi, Francesco ^a   Guarneri, Fabrizio ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; BACTERIAL PROTEIN; EPITOPE; HLA DR ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DR5 ANTIGEN; HLA DR8 ANTIGEN; HLA DR9 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OUTER SURFACE PROTEIN A; SODIUM IODIDE SYMPORTER; T LYMPHOCYTE RECEPTOR; THYROGLOBULIN; THYROID PEROXIDASE; THYROTROPIN RECEPTOR; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BINDING SITE; BORRELIA BURGDORFERI; HASHIMOTO DISEASE; HLA SYSTEM; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; THYROID FOLLICLE CELL; YERSINIA ENTEROCOLITICA;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AUTOANTIGENS; BACTERIAL PROTEINS; BORRELIA BURGDORFERI; HLA-DR ANTIGENS; HUMANS; IODIDE PEROXIDASE; RECEPTORS, THYROTROPIN; SEQUENCE HOMOLOGY, AMINO ACID; SYMPORTERS; THYROGLOBULIN; THYROID GLAND; THYROIDITIS, AUTOIMMUNE; YERSINIA;

EID: 33645508583     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.225     Document Type: Article

References (68)

1. Persidis A 1999 Autoimmune disease drug discovery. Nat Biotechnol 17:1038-1039.
2. Nieuwenhuizen WF, Pieters RHH, Knippels LMJ, Jansen MCJ, Koppelman SJ 2003 Is Candida albicans a trigger in the onset of coeliac disease? Lancet 361:2152-2154.
3. Poupon R, Poupon RE 2004 Retrovirus infection as a trigger for primary biliary cirrhosis? Lancet 363:260-261.
4. Lunardi C, Bason C, Leandri M, Navone R, Lestani M, Millo E, Benatti U, Cilli M, Beri R, Corrocher R, Puccetti A 2002 Autoantibodies to the inner ear and endothelial antigens in Cogan's syndrome. Lancet 360:915-921.
5. Vaccaro M, Guarneri F, Borgia F, Cannavo SP, Benvenga S 2002 Association of lichen sclerosus and autoimmune thyroiditis: Possible role of Borrelia burgdorferi? Thyroid 12:1147-1148.
6. Singh SK, Girschick HJ 2004 Lyme borreliosis: from infection to autoimmunity. Clin Microbiol Infect 10:598-614.
7. Benvenga S, Guarneri F, Vaccaro M, Santarpia L, Trimarchi F 2004 Homologies between proteins of Borrelia burgdorferi and thyroid autoantigens. Thyroid 14:964-966.
8. Wenzel BE, Gutekunst R, Heesemann J 1991 Hashimoto's thyroiditis and enteropathogenic Yersinia enterocolitica. In: Scherbaum W, Bogner U, Weinheimer B, Bottazzo GF (eds) Autoimmune Thyroiditis. Springer-Verlag, Berlin Heidelberg, p. 205.
9. Bech K 1991 Yersinia enterocolitica and thyroid disease. In: Scherbaum W, Bogner U, Weinheimer B, Bottazzo GF (eds) Autoimmune Thyroiditis. Springer-Verlag, Berlin Heidelberg, p. 215.
10. Çorapçioglu D, Tonyukuk V, Kiyan M, Yilmaz AE, Emral R, Kamel N, Erdogan G 2002 Relationship between thyroid autoimmunity and Yersinia enterocolitica antibodies. Thyroid 12:613-617.
11. Altschul SF, Madden TL, Schärfer AA, Zhang J, Zhang Z, Miller W, Lipman DJ 1997 Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25:3389-3402.
12. Sathiamurthy M, Hickman HD, Cavett JW, Zahoor A, Prilliman K, Metcalf S, Fernandez-Vina M, Hildebrand WH 2003 Population of the HLA ligand database. Tissue Antigens 61:12-19.
13. Martin A, Nakashima M, Zhou A, Aronson D, Werner AJ, Davies TF 1997 Detection of major T cell epitopes on human thyroid stimulating hormone receptor by overriding immune heterogeneity in patients with Graves' disease. J Clin Endocrinol Metab 82:3361-3366.
14. Pichurin P, Schwarz-Lauer L, Braley-Mullen H, Paras C, Pichurin O, Morris JC, Rapoport B, McLachlan SM 2002 Peptide scanning for thyrotropin receptor T-cell epitopes in mice vaccinated with naked DNA. Thyroid 12:755-764.
15. Akamizu T, Ueda Y, Hua L, Okuda J, Mori T 1995 Establishment and characterization of an antihuman thyrotropin (TSH) receptor-specific CD4+ T cell line from a patient with Graves' disease: evidence for multiple T cell epitopes on the TSH receptor including the transmembrane domain. Thyroid 5:259-264.
16. Nagy EV, Morris JC, Burch HB, Bhatia S, Salata K, Burman KD 1995 Thyrotropin receptor T cell epitopes in autoimmune thyroid disease. Clin Immunol Immunopathol 75:117-124.
17. Ando T, Latif R, Daniel S, Eguchi K, Davies TF 2004 Dissecting linear and conformational epitopes on the native thyrotropin receptor. Endocrinology 145:5185-5193.
18. Minich WB, Lenzner C, Morgenthaler NG 2004 Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor. Clin Exp Immunol 136:129-136.
19. Kohn LD, Harii N 2003 Thyrotropin receptor autoantibodies (TSHRAbs): Epitopes, origins and clinical significance. Autoimmunity 36:331-337.
20. Jeffreys J, Depraetere H, Sanders J, Oda Y, Evans M, Kiddie A, Richards T, Furmaniak J, Rees Smith B 2002 Characterization of the thyrotropin binding pocket. Thyroid 12:1051-1061.
21. Oda Y, Sanders J, Evans M, Kiddie A, Munkley A, James C, Richards T, Wills J, Furmaniak J, Smith BR 2000 Epitope analysis of the human thyrotropin (TSH) receptor using monoclonal antibodies. Thyroid 10:1051-1059.
22. Minich WB, Loos U 2000 Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis. Exp Clin Endocrinol Diabetes 108:110-119.
23. Shepherd PS, Da Costa CR, Cridland JC, Gilmore KS, Johnstone AP 1999 Identification of an important thyrotropin binding site on the human thyrotropin receptor using monoclonal antibodies. Mol Cell Endocrinol 149:197-206.
24. Vlase H, Nakashima M, Graves PN, Tomer Y, Morris JC, Davies TF 1995 Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: Evidence for intramolecular epitope spreading. Endocrinology 136:4415-4423.
25. Gentile F, Conte M, Formisano S 2004 Thyroglobulin as an autoantigen: What can we learn about immunopathogenicity from the correlation of antigenic properties with protein structure? Immunology 112:13-25.
26. Gora M, Gardas A, Watson PF, Hobby P, Weetman AP, Sutton BJ, Banga JP 2004 Key residues contributing to dominant conformational autoantigenic epitopes on thyroid peroxidase identified by mutagenesis. Biochem Biophys Res Commun 320:795-801.
27. Bresson D, Pugniere M, Roquet F, Rebuffat SA, N-Guyen B, Cerutti M, Guo J, McLachlan SM, Rapoport B, Estienne V, Ruf J, Chardes T, Peraldi-Roux S 2004 Directed mutagenesis in region 713-720 of human thyroperoxidase assigns 713KFPED717 residues as being involved in the B domain of the discontinuous immunodominant region recognized by human autoantibodies. J Biol Chem 279:39058-39067.
28. Gora M, Gardas A, Wiktorowicz W, Hobby P, Watson PF, Weetman AP, Sutton BJ, Banga JP 2004 Evaluation of conformational epitopes on thyroid peroxidase by antipeptide antibody binding and mutagenesis. Clin Exp Immunol 136:137-144.
29. Bresson D, Cerutti M, Devauchelle G, Pugniere M, Roquet F, Bes C, Bossard C, Chardes T, Peraldi-Roux S 2003 Localization of the discontinuous immunodominant region recognized by human anti-thyroperoxidase autoantibodies in autoimmune thyroid diseases. J Biol Chem 278:9560-9569.
30. Guo J, McLachlan SM, Rapoport B 2002 Localization of the thyroid peroxidase autoantibody immunodominant region to a junctional region containing portions of the domains homologous to complement control protein and myeloperoxidase. J Biol Chem 277:40189-40195.
31. Fisfalen ME, Soliman M, Okamoto Y, Soltani K, DeGroot LJ 1995 Proliferative responses of T-cells to thyroid antigens and synthetic thyroid peroxidase peptides in autoimmune thyroid disease. J Clin Endocrinol Metab 80:1597-1604.
32. Kemp EH, Waterman EA, Ajjan RA, Smith KA, Watson PF, Ludgate ME, Weetman AP 2001 Identification of antigenic domains on the human sodium-iodide symporter which are recognized by autoantibodies from patients with autoimmune thyroid disease. Clin Exp Immunol 124:377-385.
33. Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RC, Doniach D, Bottazzo GF 1983 Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 2:1111-1115.
34. De Libero G, Moran AP, Gober HJ, Rossy E, Shamshiev A, Chelnokova O, Mazorra Z, Vendetti S, Sacchi A, Prendergast MM, Sansano S, Tonevitsky A, Landmann R, Mori L 2005 Bacterial infections promote T cell recognition of self-glycolipids. Immunity 22:763-772.
35. Perschinka H, Mayr M, Millonig G, Mayerl C, van der Zee R, Morrison SG, Morrison RP, Xu Q, Wick G 2003 Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler Thromb Vasc Biol 23:1060-1065.
36. Yokota SI, Hirata D, Minota S, Higashiyama T, Kurimoto M, Yanagi H, Yura T, Kubota H 2000 Autoantibodies against chaperonin CCT in human sera with rheumatic autoimmune diseases: comparison with antibodies against other Hsp60 family proteins. Cell Stress Chaperones 5:337-346.
37. Handley HH, Yu J, Yu DT, Singh B, Gupta RS, Vaughan JH 1996 Autoantibodies to human heat shock protein (hsp)60 may be induced by Escherichia coli groEL. Clin Exp Immunol 103:429-435.
38. McLachlan SM, Rapoport B 1989 Evidence for a potential common T-cell epitope between human thyroid peroxidase and human thyroglobulin with implications for the pathogenesis of autoimmune thyroid disease. Autoimmunity 5:101-106.
39. Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M 1983 Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2:1115-1119.
40. Marsh PE, Parham P, Barber LD (Eds.) 2000 The HLA Facts Book. HLA class I and II molecules present peptide antigens to different types of T cell. Academic Press, San Diego, pp. 40-72.
41. McLachlan SM, Rapoport B 2000 Genetic factors in thyroid disease. In: Braverman LE, Utiger RD (eds) Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, 8th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 474.
42. Ban Y, Tomer Y 2005 Susceptibility genes in thyroid autoimmunity. Clin Dev Immunol 12:47-58.
43. Tomer Y, Davies TF 1993 Infection, thyroid disease, and autoimmunity. Endocr Rev 14:107-120.
44. Hawkins BR, Lam KS, Ma JT, Wang C, Yeung RT 1987 Strong association between HLA DRw9 and Hashimoto's thyroiditis in Southern Chinese. Acta Endocrinol 114:543-546.
45. Chan SH, Lin YN, Wee GB, Ren EC, Lui KF, Cheah JS 1993 Human leukocyte antigen DNA typing in Singaporean Chinese patients with Graves' disease. Ann Acad Med Singapore 22:576-579.
46. Tsai K, Hsieh RP, Chang CC, Chen FW, Lee SC 1989 Association of HLA-DR tissue types with Graves' disease in Taiwan. Taiwan Yi, Xue Hui Za Zhi 88:336-341.
47. La Nasa G, Martino E, Carcassi C, Mulargia M, Floris L, Vacca A, Baldini G, Orru S, Ledda A, Grasso L 1991 Serological and molecular studies of HLA in Sardinian patients with Graves' disease. Dis Markers 9:307-312.
48. Sridama V, Hara Y, Fauchet R, DeGroot LJ 1987 HLA immunogenetics heterogeneity in black American patients with Graves' disease. Arch Intern Med 147:229-231.
49. Payami H, Joe S, Farid NR, Stenszky V, Chan SH, Yeo PP, Cheah JS, Thomson G 1989 Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet 45:541-546.
50. Frecker M, Mercer G, Skanes VM, Farid NR 1988 Major histocompatibility complex (MHC) factors predisposing to and protecting against Graves' eye disease. Autoimmunity 1:307-315.
51. de Bruin TW, Bolk JH, Bussemaker JK, Stijnen T, Schreuder GM, de Vries RR, van der Heide D1988 Graves' disease: immunological and immunogenetic indicators of relapse. Br Med J (Clin Res Ed) 296:1292-1295.
52. Orhan Y, Azezli A, Carin M, Aral F, Sencer E, Molvalilar S 1993 Human lymphocyte antigens (HLA) and Graves' disease in Turkey. J Clin Immunol 13:339-343.
53. Uchigata Y, Kuwata S, Tsushima T, Tokunaga K, Miyamoto M, Tsuchikawa K, Hirata Y, Juji T, Omori Y 1993 Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406. J Clin Endocrinol Metab 77:249-254.
54. Chen QY, Huang W, She JX, Baxter F, Volpe R 1999 HLA-DRB1*08, DRB1*03/DRB3*0101 and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective. J Clin Endocrinol Metab 84:3182-3186.
55. Perrild H, Lavard L, Brock-Jacobsen B 1997 Clinical aspects and treatment of juvenile Graves' disease. Exp Clin Endocrinol Diabetes 105(Suppl 4):55-57
56. Dong RP, Kimura A, Okubo R, Shinagawa H, Tamai H, Nishimura Y, Sasazuki T 1992 HLA-A and DPB1 loci confer susceptibility to Graves' disease. Hum Immunol 35:165-172.
57. Shinagawa H 1990 The effects of HLA class II genes on the susceptibility to autoimmune thyroid diseases. Fukuoka Igaku Zasshi 81:97-111
58. Gonzales-Trevino O, Yamamoto-Furusho JK, Cutino-Moguel T, Hernandez-Martinez B, Rodriguez-Reyna TS, Ruiz-Morales JA, Vargas-Alarcon G, Granados J 2002 HLA study on two Mexican Mestizo families with autoimmune thyroid disease. Autoimmunity 35:265-269.
59. Frecker M, Stentszky V, Balazs C, Kozma L, Kraszits E, Farid NR 1986 Genetic factors in Graves' ophthalmopathy. Clin Endocrinol 25:479-485.
60. Sidel'nikova SM, Kut'ina RM, Zotikov EA 1998 HLA-antigens and some pathogenetic aspects of reactive arthritis. Ter Arkh 70:20-24.
61. Wang P, Hilton E 2001 Contribution of HLA alleles in the regulation of antibody production in Lyme disease. Front Biosci 6:B10-B16.
62. Kruger H, Heim E, Schuknecht B, Scholz S 2001 Acute and chronic neuroborreliosis with and without CNS involvement: A clinical, MRI, and HLA study of 27 cases. J Neurol 238:271-280.
63. Pfluger KH, Reimers CD, Neubert U, Meisel C, Trapp B, Leititis J, Volker B, Munchhoff P, Litzenberger J, Holthausen H1989 Lyme-borreliosis and possible association with HLA-antigens. Tissue Antigens 33:375-381.
64. Steere AC, Dweyer E, Winchester R 1990 Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med 323:219-223.
65. Steere AC, Gross D, Meyer AL, Huber BT 2001 Autoimmune mechanisms in antibiotic treatment-resistant Lyme artrhitis. J Autoimmunity 16:253-268.
66. Bagnasco M, Pesce GP, Caretto A, Paolieri F, Pronzato C, Villaggio B, Giordano C, Betterle C, Canonica GW 1995 Follicular thyroid cells of autoimmune thyroiditis may co-express ICAM-1 (CD54) and its natural ligand LFA-1 (CD11a/CD18). J Allergy Clin Immunol 95:1036-1043.
67. Nepom GT 1995 Class II antigens and disease susceptibility. Annu Rev Med 46:17-25.
68. Phelps RG, Jones V, Neil Turner A, Rees AJ 2000 Properties of HLA class II molecules divergently associated with Goodpasture's disease. Int Immunology 12:1135-1143.